Previous studies have shown that SETD2 mutations correlate with high stage and grade, and higher risk of recurrence in ccRCC patients, indicating that SETD2 and H3K36me3 play a role in driving invasion and early metastasis [2, 46]. The gene discussed is SETD2; the disease is nonpapillary renal cell carcinoma.